Brenda F. Baker
Ionis Pharmaceuticals (United States)
View profile
Collaboration graph - direct co-authors and who they connect you to
Ionis Pharmaceuticals (United States)
Brenda F. Baker (Ionis Pharmaceuticals (United States)) has co-authored with 127 scholars at 27 institutions, between 1985 and 2025. 29 of them within the last 4 years. Strongest collaborators, by shared papers: Richard S. Geary, Rosanne M. Crooke, Stephen G. Hughes, Brett P. Monia, Stanley T. Crooke and Mark J. Graham. 2 scholars on JRNLClub are one introduction away.
The strongest 12 of 127, by shared papers.
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
with Stephen G. Hughes, Brett P. Monia and 9 more · 2018 · New England Journal of Medicine · 1,455 citations · DOI
RNA-Targeted Therapeutics
with Stanley T. Crooke, C. Frank Bennett and 1 more · 2019 · Cell Metabolism · 840 citations · DOI
Antisense technology: an overview and prospectus
with Rosanne M. Crooke and Stanley T. Crooke · 2021 · Nature Reviews Drug Discovery · 778 citations · DOI
Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
with Richard S. Geary, Rosanne M. Crooke and 5 more · 2017 · New England Journal of Medicine · 573 citations · DOI
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
with Richard S. Geary, Rosanne M. Crooke and 6 more · 2015 · New England Journal of Medicine · 528 citations · DOI
h-index 213